TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 23786856

Group type: EXPERIMENTAL
Intervention: Max electrogram-guided approach
Number of subjects: 80

Group type: COMPARATOR
Intervention: Linear approach
Number of subjects: 80
Study: 21696982

Group type: EXPERIMENTAL
Intervention: NV1FGF (riferminogene pecaplasmid) administered intramuscularly
Number of subjects: 525

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 525
Study: 19476405

Group type: EXPERIMENTAL
Intervention: Intranasal phototherapy (allergy reliever SN‐206) used three times a day for 14 days
Number of subjects: 101

Group type: COMPARATOR
Intervention: Placebo device used three times a day for 14 days
Number of subjects: 101
Study: 16843257

Group type: EXPERIMENTAL
Intervention: Mannequin group (35 students)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control group (32 students)
Number of subjects: 67
Study: 12766717

Group type: EXPERIMENTAL
Intervention: Levosimendan
Number of subjects: 195

Group type: COMPARATOR
Intervention: Dobutamine
Number of subjects: 195
Study: 11075942

Group type: EXPERIMENTAL
Intervention: Amprenavir/lamivudine/zidovudine
Number of subjects: 232

Group type: COMPARATOR
Intervention: lamivudine/zidovudine
Number of subjects: 232
Study: 9488894

Group type: EXPERIMENTAL
Intervention: Angiotensin II 1 ng kg‐1 min‐1
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Angiotensin II 2 ng kg‐1 min‐1
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Angiotensin II (in vitro)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Angiotensin II (3 x 10(‐7)M and 10(‐6)M)
Number of subjects: 8
Study: 8453387

Group type: EXPERIMENTAL
Intervention: Medication discharge planning program (experimental group)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Usual informal discharge planning (control group)
Number of subjects: 54
Study: 3530897

Group type: COMPARATOR
Intervention: Ranitidine 300 mg nocte (once at night)
Number of subjects: 594

Group type: EXPERIMENTAL
Intervention: Ranitidine 150 mg twice daily
Number of subjects: 594

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 594
Study: 29794099

Group type: EXPERIMENTAL
Intervention: Coordination exercises with concurrent mental tasks
Number of subjects: 500

Group type: COMPARATOR
Intervention: Multisport exercises with mental tasks
Number of subjects: 500

Group type: COMPARATOR
Intervention: Multisport exercises without mental tasks
Number of subjects: 500
Study: 26395402

Group type: EXPERIMENTAL
Intervention: Learning goals
Number of subjects: 90
Study: 24717684

Group type: EXPERIMENTAL
Intervention: Very low carbohydrate, high fat, non calorie‐restricted diet (LCK)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Moderate carbohydrate, low fat, calorie‐restricted diet (MCCR)
Number of subjects: 34
Study: 22180581

Group type: EXPERIMENTAL
Intervention: ASSIST programme (peer-led intervention)
Number of subjects: 10730

Group type: COMPARATOR
Intervention: Usual smoking education (control)
Number of subjects: 10730
Study: 20674149

Group type: EXPERIMENTAL
Intervention: 500 U of BoNTA
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: 750 U of BoNTA
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: 500 U and 750 U of BoNTA
Number of subjects: 77
Study: 19138010

Group type: EXPERIMENTAL
Intervention: Single illumination of 100 Jcm(‐2) after 5 hours of incubation with 20% 5‐ALA
Number of subjects: 51

Group type: COMPARATOR
Intervention: Two light fractions (50 plus 50 Jcm(‐2)) after 16 hours of incubation with 20% 5‐ALA
Number of subjects: 51
Study: 15821888

Group type: EXPERIMENTAL
Intervention: HAART (Highly Active Antiretroviral Therapy) for six months
Number of subjects: 10
Study: 12456128

Group type: EXPERIMENTAL
Intervention: Project 4-Health program
Number of subjects: 1853

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 1853
Study: 9512856

Group type: EXPERIMENTAL
Intervention: Laryngeal Mask Airway (LMA) removal
Number of subjects: 60

Group type: COMPARATOR
Intervention: Tracheal extubation
Number of subjects: 60
Study: 7899367

Group type: EXPERIMENTAL
Intervention: Chemotherapy for small cell lung carcinoma
Number of subjects: 1280

Group type: COMPARATOR
Intervention: Pretherapeutic factors (Karnofsky index, alkaline phosphatase level, white cell count, age, presence of brain metastasis, presence of liver metastasis, initial extension)
Number of subjects: 1280
Study: 2795362

Group type: EXPERIMENTAL
Intervention: Whey-dominant formula
Number of subjects: 19

Group type: COMPARATOR
Intervention: Casein-dominant formula
Number of subjects: 19
Study: 144378

Group type: EXPERIMENTAL
Intervention: Topically administered amine fluorides
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 29508695

Group type: EXPERIMENTAL
Intervention: HMB-FA (3 g/d)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Both conditions
Number of subjects: 11
Study: 27440716

Group type: EXPERIMENTAL
Intervention: Time-varying spectral analysis of EDA (TVSymp)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Time-domain and time-invariant spectral indices
Number of subjects: 12
Study: 25052410

Group type: EXPERIMENTAL
Intervention: Doxylamine-vitamin B6 combination (Diclectin)
Number of subjects: 257

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 257
Study: 23033348

Group type: EXPERIMENTAL
Intervention: Prethrombolytic antihypertensive treatment (AHT)
Number of subjects: 534

Group type: COMPARATOR
Intervention: No prethrombolytic antihypertensive treatment (AHT)
Number of subjects: 534
Study: 20099956

Group type: EXPERIMENTAL
Intervention: Contingency Management (CM)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: CM + RP
Number of subjects: 100

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 100
Study: 18932056

Group type: EXPERIMENTAL
Intervention: Comprehensive prevention programme including hazard assessments, changes to housekeeping procedures, introduction of preventive products, awareness campaigns, and flooring changes.
Number of subjects: 0
Study: 15965279

Group type: EXPERIMENTAL
Intervention: Intramuscular iron (200 mg daily)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Transfusion
Number of subjects: 15
Study: 11847511

Group type: EXPERIMENTAL
Intervention: Macrolides
Number of subjects: 365

Group type: COMPARATOR
Intervention: Cephalosporins
Number of subjects: 365
Study: 10231333

Group type: EXPERIMENTAL
Intervention: 200 microg salbutamol
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 8676931

Group type: EXPERIMENTAL
Intervention: Three-drug group (rifabutin 600 mg daily, ethambutol, clarithromycin 1000 mg twice daily)
Number of subjects: 229

Group type: EXPERIMENTAL
Intervention: Three-drug group
Number of subjects: 229

Group type: EXPERIMENTAL
Intervention: Three-drug group (rifabutin 600 mg)
Number of subjects: 229

Group type: COMPARATOR
Intervention: Four-drug group (rifampin, ethambutol, clofazimine, ciprofloxacin)
Number of subjects: 229

Group type: EXPERIMENTAL
Intervention: Three-drug group (rifabutin 300 mg)
Number of subjects: 229
Study: 1857652

Group type: EXPERIMENTAL
Intervention: Classical music
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Intrauterine sounds
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Pacifier
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Music and pacifier
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Intrauterine sounds and pacifier
Number of subjects: 121

Group type: COMPARATOR
Intervention: Control (no nurses present and no pain reduction interventions)
Number of subjects: 121
Study: 6287835

Group type: EXPERIMENTAL
Intervention: Hydroxyapatite (HA)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Calcium gluconate (CG)
Number of subjects: 64

Group type: COMPARATOR
Intervention: No mineral supplements (Control)
Number of subjects: 64
Study: 30194457

Group type: EXPERIMENTAL
Intervention: Thulium laser enucleation of the prostate (ThuLEP)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Thulium laser resection of the prostate (TmLRP)
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Both interventions (ThuLEP and TmLRP)
Number of subjects: 115
Study: 28201821

Group type: EXPERIMENTAL
Intervention: Cane group (using a cane daily whenever walking for 12 weeks)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not using any gait aid for 12 weeks)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cane group
Number of subjects: 0
Study: 26273472

Group type: EXPERIMENTAL
Intervention: Group-based Mindfulness-Based Cognitive Therapy (MBCT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Individual internet-based Mindfulness-Based Cognitive Therapy (MBCT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Group-based MBCT
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Individual internet-based MBCT
Number of subjects: 0

Group type: COMPARATOR
Intervention: TAU
Number of subjects: 0
Study: 24639421

Group type: EXPERIMENTAL
Intervention: Healthy Beginnings (HB) intervention
Number of subjects: 0
Study: 22237690

Group type: EXPERIMENTAL
Intervention: Alogliptin (Alo)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Alogliptin/Pioglitazone (Alo/Pio)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Placebo (Pbo)
Number of subjects: 71
Study: 20846363

Group type: EXPERIMENTAL
Intervention: Recombinant human follicle-stimulating hormone
Number of subjects: 4040

Group type: COMPARATOR
Intervention: Human menopausal gonadotrophins
Number of subjects: 4040
Study: 17662390

Group type: EXPERIMENTAL
Intervention: Hyperoxemic reperfusion with aqueous oxygen (AO) for 90 min after PCI
Number of subjects: 269

Group type: COMPARATOR
Intervention: Normoxemic blood autoreperfusion (control group)
Number of subjects: 269

Group type: COMPARATOR
Intervention: Both groups (AO and control)
Number of subjects: 269
Study: 16096751

Group type: EXPERIMENTAL
Intervention: Lung recruitment maneuver (10 seconds)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Lung recruitment maneuver (20 seconds)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Lung recruitment maneuver (first maneuver)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Lung recruitment maneuver (second maneuver)
Number of subjects: 10
Study: 11844417

Group type: EXPERIMENTAL
Intervention: Denture Brite
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Polident
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Efferdent
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (water)
Number of subjects: 0
Study: 9972772

Group type: EXPERIMENTAL
Intervention: PGE1 at a dose of 0.02 microg x kg(‐1) x min(‐1) (PG20 group)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: PGE1 at a dose of 0.05 microg x kg(‐1) x min(‐1) (PG50 group)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Control group (no PGE1)
Number of subjects: 83
Study: 8775774

Group type: EXPERIMENTAL
Intervention: Locally applied vaginal conjugated estrogen cream
Number of subjects: 67

Group type: COMPARATOR
Intervention: Atrophic vaginitis
Number of subjects: 67
Study: 2206018

Group type: EXPERIMENTAL
Intervention: Norinyl 1 + 35
Number of subjects: 300

Group type: COMPARATOR
Intervention: Norinyl 1 + 50
Number of subjects: 300
Study: 6126013

Group type: EXPERIMENTAL
Intervention: Halothane
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Fluroxene
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Enflurane
Number of subjects: 24

Group type: COMPARATOR
Intervention: Nitrous oxide-barbiturate-narcotic (Control)
Number of subjects: 24
Study: 31483146

Group type: EXPERIMENTAL
Intervention: Mechanical breast pumps
Number of subjects: 50

Group type: COMPARATOR
Intervention: Hand expression
Number of subjects: 50

Group type: COMPARATOR
Intervention: Direct breastfeeding
Number of subjects: 50
Study: 28106471

Group type: EXPERIMENTAL
Intervention: Topical 0.1% bromfenac sodium
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control placebo
Number of subjects: 60
Study: 25663312

Group type: EXPERIMENTAL
Intervention: Fast-array imaging mode
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Array imaging mode
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: High-definition imaging mode
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: TBS
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: BMD
Number of subjects: 30

Group type: COMPARATOR
Intervention: Imaging modes comparison
Number of subjects: 30
Study: 24396024

Group type: EXPERIMENTAL
Intervention: Chlorthalidone 25 mg for 8 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (ongoing antihypertensive treatment)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Chlorthalidone and Control
Number of subjects: 60
Study: 18381951

Group type: EXPERIMENTAL
Intervention: DMXAA (doses of 6 to 4,900 mg/m², administered as a 20-minute i.v. infusion weekly or every 3 weeks)
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: DMXAA
Number of subjects: 124
Study: 14741299

Group type: EXPERIMENTAL
Intervention: Toe-standing
Number of subjects: 10

Group type: COMPARATOR
Intervention: Heel-toe standing
Number of subjects: 10
Study: 10842410

Group type: EXPERIMENTAL
Intervention: Squat lift training
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Free weight resistance training
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 36
Study: 9338928

Group type: EXPERIMENTAL
Intervention: Magnetic resonance imaging (MRI)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control group (mechanical spinal disease)
Number of subjects: 31
Study: 8115560

Group type: EXPERIMENTAL
Intervention: Blind counselor (described as a blind doctoral student)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (informed that the counselor was a doctoral student)
Number of subjects: 0
Study: 3758367

Group type: EXPERIMENTAL
Intervention: Totally implantable Infusaid‐400 pumps
Number of subjects: 39

Group type: COMPARATOR
Intervention: Implantable ports
Number of subjects: 39
Study: 31781758

Group type: EXPERIMENTAL
Intervention: Prospective urine testing for TB diagnostics
Number of subjects: 322

Group type: COMPARATOR
Intervention: Standard of care (retrospective urine testing)
Number of subjects: 322
Study: 28409660

Group type: EXPERIMENTAL
Intervention: Celecoxib (100 mg twice daily)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 25981836

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control (Normal Saline)
Number of subjects: 80
Study: 23772682

Group type: EXPERIMENTAL
Intervention: FRDMS
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: FRD
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control
Number of subjects: 48
Study: 23503992

Group type: EXPERIMENTAL
Intervention: Feedback on response accuracy
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Feedback‐plus (response accuracy plus correct answer)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Direct instruction
Number of subjects: 71
Study: 19321521

Group type: EXPERIMENTAL
Intervention: Additional one‐hour session of task‐specific motor training for the hand five times a week over a six‐week period
Number of subjects: 39

Group type: COMPARATOR
Intervention: Standard care consisting of 10 minutes of hand therapy three times a week
Number of subjects: 39
Study: 17705092

Group type: EXPERIMENTAL
Intervention: Laparoscopy-assisted distal gastrectomy (LADG) with D2 lymph node dissection
Number of subjects: 64

Group type: COMPARATOR
Intervention: Open distal gastrectomy with D2 lymph node dissection (from pilot study)
Number of subjects: 64
Study: 15803229

Group type: EXPERIMENTAL
Intervention: Early laparoscopic cholecystectomy within 24 hours of admission
Number of subjects: 40

Group type: COMPARATOR
Intervention: Delayed laparoscopic cholecystectomy (6 to 12 weeks later)
Number of subjects: 40
Study: 11339782

Group type: EXPERIMENTAL
Intervention: Diclofenac 100 mg suppository
Number of subjects: 48

Group type: COMPARATOR
Intervention: No diclofenac suppository (Control)
Number of subjects: 48
Study: 9238893

Group type: EXPERIMENTAL
Intervention: Rota‐dent, Pro‐Dentec Inc.
Number of subjects: 35

Group type: COMPARATOR
Intervention: Interplak, Bausch and Lomb Inc.
Number of subjects: 35
Study: 8431589

Group type: EXPERIMENTAL
Intervention: Accelerated rehabilitation programme
Number of subjects: 261

Group type: COMPARATOR
Intervention: Conventional care
Number of subjects: 261
Study: 2890728

Group type: EXPERIMENTAL
Intervention: 10 mg APM/kg body weight
Number of subjects: 18

Group type: COMPARATOR
Intervention: Unsweetened beverage
Number of subjects: 18

Group type: COMPARATOR
Intervention: 4 mg/kg body weight as aspartame (APM)
Number of subjects: 18
Study: 29417877

Group type: EXPERIMENTAL
Intervention: GENEActiv accelerometer at baseline and 18-month follow-up
Number of subjects: 886
Study: 27565253

Group type: EXPERIMENTAL
Intervention: Luteal phase support using vaginal progesterone gel (n = 202)
Number of subjects: 393

Group type: COMPARATOR
Intervention: No luteal phase support (n = 191)
Number of subjects: 393
Study: 24002227

Group type: EXPERIMENTAL
Intervention: Individual cognitive-behavioral therapy (CBT) based on the modified Coping Cat Program
Number of subjects: 24

Group type: COMPARATOR
Intervention: Treatment as usual intervention
Number of subjects: 24
Study: 22247123

Group type: EXPERIMENTAL
Intervention: Linezolid (600 mg every 12 hours)
Number of subjects: 1184

Group type: COMPARATOR
Intervention: Vancomycin (15 mg/kg every 12 hours)
Number of subjects: 1184

Group type: EXPERIMENTAL
Intervention: Linezolid
Number of subjects: 1184

Group type: COMPARATOR
Intervention: Vancomycin
Number of subjects: 1184
Study: 20674827

Group type: EXPERIMENTAL
Intervention: Montelukast (n = 28)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Placebo (n = 26)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (200 microg daily)
Number of subjects: 102
Study: 18235151

Group type: EXPERIMENTAL
Intervention: Sarpogrelate (300 mg/d)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Aspirin (100 mg/d)
Number of subjects: 40
Study: 15963401

Group type: EXPERIMENTAL
Intervention: Nocturnal continuous positive airway pressure (CPAP) treatment
Number of subjects: 17

Group type: COMPARATOR
Intervention: No CPAP (control)
Number of subjects: 17
Study: 14673984

Group type: EXPERIMENTAL
Intervention: Tacrolimus 2 mg
Number of subjects: 464

Group type: EXPERIMENTAL
Intervention: Tacrolimus 3 mg
Number of subjects: 464

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 464
Study: 11166502

Group type: EXPERIMENTAL
Intervention: Senior Professor (SP) intervention, utilizing experienced clinical and managerial staff for program induction seminars during the first weeks of admissions.
Number of subjects: 605

Group type: COMPARATOR
Intervention: Standard or non-enhanced treatment (control group).
Number of subjects: 605
Study: 8996671

Group type: EXPERIMENTAL
Intervention: Vibration exposure (3-12 m/s²) with varying directions (Xh, Yh, Zh) and grip forces (25-75 N)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Individual biological factors (age, hand volume, hand thickness)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Blood pressure
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Subjective symptoms (finger blanching, numbness) and nicotine use
Number of subjects: 84
Study: 1479133

Group type: EXPERIMENTAL
Intervention: 1 h of morning light treatment (about 7000 lux)
Number of subjects: 32

Group type: COMPARATOR
Intervention: 1 h of morning placebo treatment (deactivated negative ion generator)
Number of subjects: 32
Study: 6361287

Group type: EXPERIMENTAL
Intervention: High dose methylprednisolone (1,000-mg bolus and daily thereafter for ten days)
Number of subjects: 330

Group type: COMPARATOR
Intervention: Standard dose methylprednisolone (100-mg bolus and daily thereafter for ten days)
Number of subjects: 330

Group type: EXPERIMENTAL
Intervention: High dose methylprednisolone
Number of subjects: 330
Study: 31345170

Group type: EXPERIMENTAL
Intervention: Telephone counseling for caregivers and multicomponent therapy for cognitively impaired persons in day-care centers.
Number of subjects: 359
Study: 30189000

Group type: EXPERIMENTAL
Intervention: Electronic home medication review tool (before admission)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Electronic home medication review tool (after admission)
Number of subjects: 65
Study: 26826544

Group type: EXPERIMENTAL
Intervention: 4CMenB
Number of subjects: 264

Group type: COMPARATOR
Intervention: Control (placebo followed by MenACWY‐CRM)
Number of subjects: 264
Study: 24603863

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study: 22409245

Group type: EXPERIMENTAL
Intervention: Interactive gaming program (n=22)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Conventional physiotherapy (n=22)
Number of subjects: 44
Study: 20965863

Group type: EXPERIMENTAL
Intervention: Suture repair in small hernia (n = 247)
Number of subjects: 953

Group type: COMPARATOR
Intervention: Mesh repair in small hernia (n = 247)
Number of subjects: 953

Group type: EXPERIMENTAL
Intervention: Onlay mesh reconstruction in large hernia (n = 224)
Number of subjects: 953

Group type: COMPARATOR
Intervention: Sublay mesh reconstruction in large hernia (n = 235)
Number of subjects: 953
Study: 17686105

Group type: EXPERIMENTAL
Intervention: Immunotherapy for allergic rhinoconjunctivitis
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 15776297

Group type: EXPERIMENTAL
Intervention: Ketoprofen 100 mg i.v. administered at 1 and 9 hours postoperatively
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Ketoprofen 100 mg i.v.
Number of subjects: 43
Study: 12039480

Group type: EXPERIMENTAL
Intervention: Transfer for primary PTCA
Number of subjects: 138

Group type: COMPARATOR
Intervention: On-site thrombolysis
Number of subjects: 138
Study: 9659670

Group type: EXPERIMENTAL
Intervention: Transdermal nicotine application (17.5 mg day‐1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Transdermal nicotine application (35 mg day‐1)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Baseline (predefaecation)
Number of subjects: 0
Study: 8087519

Group type: EXPERIMENTAL
Intervention: 30 mg/m2 cisplatin weekly + radiotherapy
Number of subjects: 331

Group type: EXPERIMENTAL
Intervention: 6 mg/m2 cisplatin daily + radiotherapy
Number of subjects: 331

Group type: COMPARATOR
Intervention: Radiotherapy alone
Number of subjects: 331
Study: 2789927

Group type: EXPERIMENTAL
Intervention: Continuous infusion of oxytocin (0.33 u min‐1)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Administration of oxytocin
Number of subjects: 10